Vivimed Labs Ltd Quarterly Results

Gross Sales

20.61

21.39

25.61

36.51

24.77

Excise Duty

0

0

0

0

0

Net Sales

20.61

21.39

25.61

36.51

24.77

Other Operating Income

0

0

0

0

0

Other Income

0.21

0.38

4.22

0.07

0.03

Total Income

20.82

21.77

29.83

36.58

24.8

Total Expenditure

21.57

21.67

28.08

35.45

25.41

PBIDT

-0.74

0.1

1.75

1.12

-0.61

Interest

1.66

0.58

1.74

0.48

0.43

PBDT

-2.4

-0.48

0.01

0.64

-1.04

Depreciation

4.9

5.01

5.5

6.62

4.1

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0.23

0

0

Deferred Tax

0

0

-0.11

0

0

Reported Profit After Tax

-7.3

-5.49

-5.6

-5.98

-5.14

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-7.3

-5.49

-5.6

-5.98

-5.14

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-7.3

-5.49

-5.6

-5.98

-5.14

EPS (Unit Curr.)

-0.88

-0.66

-0.68

-0.72

-0.62

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

16.58

16.58

16.58

16.58

16.58

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-3.59

0.46

6.83

3.06

-2.46

PBDTM(%)

-11.64

-2.24

0.03

1.75

-4.19

PATM(%)

-35.41

-25.66

-21.86

-16.37

-20.75